Becton invests $3 million in Lucent:
This article was originally published in Clinica
Becton Dickinson has acquired 19.9% of Lucent Medical. The Seattle-based Lucent is developing low-cost intelligent infusion therapy and surgical devices. Becton invested $3 million. Other companies putting money into Lucent in its second round of funding included JAFCO and Daiwa Business Investment, both of Tokyo. Previous investors include the University of Washington.